OSPEDALE SAN RAFFAELE SRL
- Country
- Italy
- Type
- Beneficiary
- Website
- www.hsr.it
- Grants received
- 117
Funding record
- 117 grants on record
- €59,291,116.40 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Horizon Europe Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
- Seventh Framework Programme
61 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- FONDAZIONE CENTRO SAN RAFFAELE
- UNIVERSITA VITA-SALUTE SAN RAFFAELE
- FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
- KAROLINSKA INSTITUTET
- KATHOLIEKE UNIVERSITEIT LEUVEN
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- UNIVERSITY COLLEGE LONDON
Calls from this organisation
No published calls from this organisation.
Grants received
- Enriching HDR edits for enhancing efficacy and precision of HSPC gene therapy
- Universal Cardiac Mesoangioblasts for treating DMD Dilated Cardiomyopathy
- Addressing Unknowns and Unmet Needs of VEXAS Syndrome by Multiomics Clonal Tracking and Targeted Gene Editing
- Dissect the impact, safety and effectiveness of gene therapy at the whole organismal level by cell-free DNA signatures
- UnderstandiNg fraIlty tOwards a future of healthy ageiNg
- Tackling fibrosis and inflammation in LAMA2-RD by in vivo modulation of a novel modifier gene
- IDENTIfication and tracking of cancer-prone cells in KIdney Tubules
- A Novel Glutamine (Q) Sensory Role for Primary Cilia: Implications for Health and Disease
- EUROPEAN RARE DISEASES RESEARCH ALLIANCE
- Breath Pathogen Detection (B-Path): Establishing Exhaled Breath Aerosol (XBA) sampling for diagnosis and screening of respiratory infections
- Boronic Acids as a New Strategy to Boost beta-Lactam Antibiotics for the Treatment of Tubercolosis
- Modulating Tregs in liver disease for therapeutic benefit
- Neuromorphic Polariton Accelerator
- Endoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for detecting cost effective surveillance strategies and prediction of cancer recurrence
- Establishing Exhaled Breath Aerosol (XBA) sampling for diagnosis and screening of respiratory infections
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.